Merck & Co., Inc. - stock earnings

MRK Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
Oct. 27, 2022, midnight 13.5 billion 14.3 billion 15.1 billion

MRK Quarterly earnings

DateEarningsRevenue
2020Q3 2.9 billion USD 12.6 billion USD
2020Q4 -2.1 billion USD 12.5 billion USD
2021Q1 3.2 billion USD 10.6 billion USD
2021Q2 1.5 billion USD 11.4 billion USD
2021Q3 4.6 billion USD 13.2 billion USD
2021Q4 3.8 billion USD 13.5 billion USD
2022Q1 4.3 billion USD 15.9 billion USD
2022Q2 3.9 billion USD 14.6 billion USD

MRK Yearly earnings

DateEarningsRevenue
2017 2.4 billion USD 40.1 billion USD
2018 6.2 billion USD 42.3 billion USD
2019 9.8 billion USD 39.1 billion USD
2020 7.1 billion USD 41.5 billion USD
2021 13.0 billion USD 48.7 billion USD

MRK

List: Contenders

Price: 86.12USD

52 week range price:
71.50
95.72

Dividend Yield: 2.88%

5-year range yield:
2.66%
3.74%

Forward Dividend Yield: 3.20%

Payout Ratio: 38.07%

Payout Ratio Range:
26.90%
542.90%

Dividend Per Share: 2.76 USD

Earnings Per Share: 7.25 USD

P/E Ratio: 31.00

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers—General

Volume: 6.5 million

Ebitda: 2.3 billion

Market Capitalization: 216.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 61

DGR3: 11.20%

DGR5: 8.21%

DGR10: 5.85%

DGR20: 3.55%

Links: